Seven hundred sixty participants (393 AD and 367 ED) enrolled in ADAGES (n=582) or in the Diagnostic Innovations in Glaucoma Study (DIGS) (n=178) were included in this study. Ancestry classification in these studies is based on self-report. When eligible (DIGS/ADAGES inclusion/exclusion criteria and the specific criteria required to be included in this study are explained in this section), both eyes of each participant were included (1478 eyes, including 764 AD and 714 ED eyes). DIGS is conducted at the Hamilton Glaucoma Center at the University of California, San Diego (UCSD), whereas ADAGES is a multicenter study conducted at UCSD, the University of Alabama at Birmingham (UAB), and the New York Eye and Ear Infirmary (NYEE). Protocols were in place to ensure that testing procedures were comparable at all sites. These ongoing studies are prospectively designed to assess structure and function in glaucoma. Enrollment of participants is based on the inclusion/exclusion criteria specified below. Patient participants are followed up annually, whereas only baseline data are obtained from most healthy participants (a small subset of healthy participants will have follow-up data). All ADAGES and DIGS participants with healthy eyes were included in the study reported herein. Healthy eyes were defined as having a normal appearance of the optic disc on stereoscopic photographs, intraocular pressure (IOP) of less than 22 mm Hg (measured once), no history of elevated IOP, and no use of glaucoma medication or surgery in either eye. Visual field data were not used for classification purposes. Healthy control participants for ADAGES and DIGS were recruited to join the study by advertisement, from family members of patients, and from primary eye care clinics. Informed consent was obtained from all participants, and the local institutional review board at each site approved all methods. Participants were minimally compensated for their involvement in the study. This study adhered to the tenets of the Declaration of Helsinki for research involving human subjects and conformed to the Health Insurance Portability and Accountability Act.
>
Procedures
>
Therapeutic or Preventive Procedure
>
Ophthalmologic Surgical Procedures
Ophthalmologic Surgical Procedures
Ophthalmologic Surgical Procedures encompass a diverse range of surgical interventions targeting the eye and its surrounding structures.
These procedures aim to treat various ocular conditions, enhance visual function, and improve patient outcomes.
The field includes procedures such as cataract removal, corneal transplantation, refractive surgery, and vitreoretinal interventions, among others.
Researchers in this domain leverage the latest advancements in surgical techniques, instrumentation, and medical technologies to optimize patient care and advance the field of ophthalmology.
By carefully selecting and comparing surgical protocols, researchers can ensure reproducibility, enhance surgical outcomes, and drive innovation in this critical area of healthcare.
These procedures aim to treat various ocular conditions, enhance visual function, and improve patient outcomes.
The field includes procedures such as cataract removal, corneal transplantation, refractive surgery, and vitreoretinal interventions, among others.
Researchers in this domain leverage the latest advancements in surgical techniques, instrumentation, and medical technologies to optimize patient care and advance the field of ophthalmology.
By carefully selecting and comparing surgical protocols, researchers can ensure reproducibility, enhance surgical outcomes, and drive innovation in this critical area of healthcare.
Most cited protocols related to «Ophthalmologic Surgical Procedures»
Ethics Committees, Research
Family Member
Glaucoma
Healthy Volunteers
Innovativeness
Ophthalmologic Surgical Procedures
Optic Disk
Patients
Pharmaceutical Preparations
Primary Health Care
Tests, Diagnostic
Tonometry, Ocular
Bone Marrow Transplantation
Breast
Dental Health Services
Heart
Heart Transplantation
Hospitalization
Inpatient
Neurosurgical Procedures
Operative Surgical Procedures
Ophthalmologic Surgical Procedures
Patient Discharge
Patients
Radiotherapy
Skin
Surgical Procedure, Cardiac
System, Endocrine
System, Genitourinary
Therapeutics
Vascular Surgical Procedures
Preoperative peripheral iridotomies by neodymium - yttrium - aluminum - garnet (Nd:YAG) laser or intraoperative peripheral iridotomies were performed for ICL V4 implantations and no peripheral iridotomies were performed for ICL V4c implantations. On the day of surgery, all patients were administered with dilating and cycloplegic agents (2.5 % phenylephrine and 1 % tropicamide, Alcon, China). After topical anaesthesia (0.4 % oxybuprocaine hydrochloride, Santen, Japan) and injection of a viscoelastic surgical agent (1.7 % Sodium hyaluronate; Bausch & Lomb, China) into the anterior chamber, an ICL V4 IOL was inserted via a 2.8–3.2 mm temporal clear corneal incision with the use of an injector cartridge (STAAR Surgical). After the ICL was placed in the posterior chamber, the surgeon then completely removed the viscoelastic surgical agent from the eye using a balanced salt solution and instilled a miotic agent (0.005 % carbachol, Bausch & Lomb, China). All surgeries were uneventful and no intraoperative complications were observed. Following surgery, a combination antibacterial and steroidal medication (0.1 % Tobramycin dexamethasone, Alcon, China) was prescribed four times daily for 3 days followed by fluorometholone eyedrops tapered gradually over 2 weeks. Antibiotic eyedrops (0.5 % left Ofloxacin, Santen, Japan) were then prescribed four times daily for 1 week, along with non-steroidal anti-inflammatory eyedrops (NSAID, pranoprofen, Senju, Japan) four times daily for 2 weeks, and artificial tears four times daily for 1 month.
Anti-Bacterial Agents
Anti-Inflammatory Agents, Non-Steroidal
Antibiotics
benoxinate
Carbachol
Chambers, Anterior
Cornea
Cycloplegics
Eye Drops
Fluorometholone
Intraoperative Complications
Lubricant Eye Drops
Miotics
Neodymium
Neodymium-Doped Yttrium Aluminum Garnet Lasers
Ofloxacin
Operative Surgical Procedures
Ophthalmologic Surgical Procedures
Ovum Implantation
Patients
Pharmaceutical Preparations
Phenylephrine
pyranoprofen
Sodium Chloride
Sodium Hyaluronate
Steroids
Surgeons
Surgery, Day
Tobramycin, Dexamethasone Drug Combination
Topical Anesthetics
Tropicamide
yttrium-aluminum-garnet
Arcus Senilis
Astigmatism
Cataract Extraction
Congenital Abnormality
Cornea
Cornea Injuries
Corneal Diseases
Endothelium
Epithelium
Ethnicity
Gender
Glaucoma
Hereditary Corneal Dystrophy
Infection
Keratitis
Keratoconus
Laser Surgery
Limbus Corneae
Ocular Refraction
Operative Surgical Procedures
Ophthalmologic Surgical Procedures
Pathologic Neovascularization
Phenotype
Pterygium Of Conjunctiva And Cornea
Retina
Slit Lamp Examination
Uveitis, Anterior
Wounds, Penetrating
The diagnostic criteria for early COPD are still inconclusive, so this protocol does not provide a clear definition of early COPD. We will adopt whether FEV1/FVC is greater than or less than 0.7 for enrollment in the study design, and we will further analyze the definitions of early COPD one by one in the future analysis of cohort data. This is a prospective observational cohort study among individuals aged 40–80 years in Guangdong, China. We will recruit approximately 2,000 participants (1,000 without COPD, 800 with GOLD stage 1–2, and 200 with GOLD stage 3–4) from the community using a population-based survey for COPD. Participants will complete standard respiratory epidemiological questionnaires and pre-bronchodilator and post-bronchodilator spirometry. We will also collect information regarding health outcomes [modified British Medical Research Council (mMRC) dyspnea scale, COPD assessment test (CAT) and COPD clinical questionnaire (CCQ)], We will also obtain satellite remote sensing data to assess pollutant exposure. All Participants with post-bronchodilator FEV1/FVC <0.70 will be invited to participate in the ECOPD study. According to the chronological order of spirometry completion, we will randomly invite a quarter of participants who have post-bronchodilator FEV1/FVC ≥0.70 to participate in the ECOPD study. Participants who are invited and willing to participate in the study will further complete a chest computed tomography (CT) scan, impulse oscillometry (IOS), and biomarker measurement (blood and urine). Subgroup will additionally complete induced sputum, exercise capacity tests [6-minute walk test (6MWT) and cardiopulmonary exercise testing (CPET)] and home monitoring/personal sampling as pollutant exposure measures (Figure 1 ).
The inclusion criteria are as follows: (I) aged 40–80 years; (II) willing to participate in this study and providing a signed informed consent form; (III) completing the standard respiratory epidemiological questionnaire in this study; and (IV) completing pre-bronchodilator and post-bronchodilator spirometry. The exclusion criteria are as follows: (I) aged <40 or >80 years; (II) respiratory infection or exacerbation in the 4 weeks prior to screening; (III) heart attack (myocardial infarction, malignant arrhythmia) in the past 3 months; (IV) hospitalized for heart disease within the past 1 month; (V) chest, abdomen, or eye surgery in the past 3 months; (VI) previous lobectomy; (VII) malignant tumors newly discovered and being treated; (VIII) receiving anti-tuberculosis drug treatment or active pulmonary tuberculosis; (IX) history of mental disorders, auditory hallucinations, visual hallucinations, or taking antipsychotic drugs; (X) history of cognitive disorders, including dementia or cognitive disorders; (XI) history of high paraplegia; and (XII) pregnant or lactating women. Considering that some patients with asthma have a high risk of developing COPD, a previous diagnosis of asthma confirmed by a pulmonary physician and the presence or absence of airflow reversibility will not be an exclusion criterion (22 (link),23 (link)).
The inclusion criteria are as follows: (I) aged 40–80 years; (II) willing to participate in this study and providing a signed informed consent form; (III) completing the standard respiratory epidemiological questionnaire in this study; and (IV) completing pre-bronchodilator and post-bronchodilator spirometry. The exclusion criteria are as follows: (I) aged <40 or >80 years; (II) respiratory infection or exacerbation in the 4 weeks prior to screening; (III) heart attack (myocardial infarction, malignant arrhythmia) in the past 3 months; (IV) hospitalized for heart disease within the past 1 month; (V) chest, abdomen, or eye surgery in the past 3 months; (VI) previous lobectomy; (VII) malignant tumors newly discovered and being treated; (VIII) receiving anti-tuberculosis drug treatment or active pulmonary tuberculosis; (IX) history of mental disorders, auditory hallucinations, visual hallucinations, or taking antipsychotic drugs; (X) history of cognitive disorders, including dementia or cognitive disorders; (XI) history of high paraplegia; and (XII) pregnant or lactating women. Considering that some patients with asthma have a high risk of developing COPD, a previous diagnosis of asthma confirmed by a pulmonary physician and the presence or absence of airflow reversibility will not be an exclusion criterion (22 (link),23 (link)).
6-Minute Walk Test
Abdomen
Antipsychotic Agents
Antitubercular Agents
Asthma
Biological Markers
BLOOD
Bronchodilator Agents
Cardiac Arrhythmia
Chest
Chronic Obstructive Airway Disease
Cognition Disorders
Dementia
Diagnosis
Dyspnea
Environmental Pollutants
Exercise Tests
Gold
Hallucinations, Auditory
Hallucinations, Visual
Heart Diseases
Lung
Malignant Neoplasms
Mental Disorders
Myocardial Infarction
Ophthalmologic Surgical Procedures
Oscillometry
Paraplegia
Patients
Physicians
Radionuclide Imaging
Respiratory Rate
Respiratory Tract Infections
Spirometry
Sputum, Induced
Tuberculosis, Pulmonary
Urine
Woman
X-Ray Computed Tomography
Most recents protocols related to «Ophthalmologic Surgical Procedures»
Before hospital discharge, both groups were booked for follow-up on POD 2 and were notified of their appointment by a phone message at discharge.
Participants in the TEL group received follow-up by telephone consultation. The calls were placed during the daytime on POD 2. Telephone consultations were entirely made in Chinese by a trained certified research nurse, using a standard questionnaire to ensure consistency. The questionnaire was created based on the most frequent postoperative complications after ophthalmic surgeries following general anesthesia [7 (link)]. If patients had additional clinical concerns, they were provided with appropriate contact information. The satisfaction level for the follow-up method was also assessed. These variables were documented as ‘yes’ or ‘no’ in the electronic medical record, and any additional patient concerns were noted as described in detail. In the QR group, patients received follow-up using QR code. A specific QR code was pre-generated to link the web version of the follow-up questionnaire (Fig.1 ), which contained questions the same as those in the group TEL. Before patient discharge, a QR code scan application (WeChat) was installed on their smartphones, and they were trained in application use, including how to move from question to question, how to input a response, and how to submit, by the nurses in the PACU. A research nurse would extract and check the responses through the computer client on the follow-up day. Based on patient responses, if the assessment demonstrated an abnormal recovery, defined as worsening pain despite the use of analgesics, signs or symptoms of uncontrolled complications (i.e., high fever, severe vomiting, etc.), or persistent bleeding at the incision site, a nurse-initiated telephone call was made to the patient with treatment advice.![]()
Participants in the TEL group received follow-up by telephone consultation. The calls were placed during the daytime on POD 2. Telephone consultations were entirely made in Chinese by a trained certified research nurse, using a standard questionnaire to ensure consistency. The questionnaire was created based on the most frequent postoperative complications after ophthalmic surgeries following general anesthesia [7 (link)]. If patients had additional clinical concerns, they were provided with appropriate contact information. The satisfaction level for the follow-up method was also assessed. These variables were documented as ‘yes’ or ‘no’ in the electronic medical record, and any additional patient concerns were noted as described in detail. In the QR group, patients received follow-up using QR code. A specific QR code was pre-generated to link the web version of the follow-up questionnaire (Fig.
Analgesics
Chinese
Conditioning, Psychology
Fever
General Anesthesia
Nurses
Ophthalmologic Surgical Procedures
Pain
Patient Discharge
Patients
Postoperative Complications
Radionuclide Imaging
Satisfaction
The present study was designed as a prospective control study. 30 eyes of 30 healthy adults were evaluated (7 male, 23 female). Mean age was 28.7 ± 11.8 years with a range of 19–60 years (women: 28.8 ± 11.4; men: 28.4 ± 13.0). According to the spherical equivalent refraction (SER), 15 emmetropic subjects (SER: +0.75 to -0.75 DS, mean: -0.13 ± 0.2 DS), 13 myopic (SER: ≤ -1.00 DS, mean: -3.46 ± 1.8 DS) and two hyperopic (SER: ≥ + 1.00 DS, mean +1.375 ± 0 DS) eyes were analyzed. A complete standardized ophthalmologic screening, including slit-lamp biomicroscopy, fundoscopy and Goldman applanation tonometry, was performed on each subject. The presence of any eye disease and previous ophthalmic surgery or laser treatment were exclusion criteria and IOP had to be within the normal range. The study protocol was approved by the local ethic committee of Erlangen and was performed in accordance with the tenets of the Declaration of Helsinki. Informed written consent, approved by the ethic committee of Erlangen, was obtained from all study participants.
Adult
Ethics Committees
Eye
Eye Disorders
Males
Myopia
Ocular Refraction
Ophthalmologic Surgical Procedures
Ophthalmoscopy
Slit Lamp Examination
Tonometry, Ocular
Woman
In this prospective, cross-sectional, and comparative investigation, 64 right eyes of 64 participants were evaluated at The University, Medical Faculty, Department of Ophthalmology. The University-Local Ethics Committee approved the study protocol (Protokol Number; 2016-58-09.03). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki, and all of the participants provided written informed consent.
The study groups were selected from patients who have been diagnosed with OSAS by PSG in the Sleep Disorder Laboratory of the Department of Thoracic Medicine but have not yet been treated. The control group was selected from healthy volunteers who applied to the ophthalmology outpatient clinic with presbyopic complaints. Both the Berlin questionnaire (9 (link)) was applied and a complete physical examination was performed by a thoracic medicine specialist (FE) to the participants to be included in the control group to exclude possible OSAS cases. The subjects who had a total score of <2 in the Berlin questionnaire and had no additional ocular and systemic diseases except controlled HT were included in the control group.
The patients who were <18 years old, who had any corneal diseases, ocular diseases requires continued medication (diseases such as glaucoma, uveitis, dry eyes, etc.), previous operation history of the eye in the past 6 months, contact lens use within last 4 weeks, the best corrected visual acuity (BCVA) <20/30 with spherical and cylindrical refraction exceeding ±3 diopter were excluded from the study. Patients who have systemic diseases that may affect the biomechanics of the cornea, such as Sjögren’s Disease, chronic renal failure, diabetes mellitus (DM), liver diseases, chronic obstructive pulmonary diseases, rheumatic, and oncological disorders were also excluded from the study.
The study group was selected according to their AHI value. While mild OSAS cases (AHI <15) were excluded, 32 eyes of 32 patients with moderate to severe OSAS (AHI ≥15; number of moderate case=16 and number of severe case=16) were included in the study (Group 1). The control group was determined as “Group 0” and 32 eyes of 32 patients were recruited in Group 0. Only the right eyes of the subjects were evaluated in both groups.
The study groups were selected from patients who have been diagnosed with OSAS by PSG in the Sleep Disorder Laboratory of the Department of Thoracic Medicine but have not yet been treated. The control group was selected from healthy volunteers who applied to the ophthalmology outpatient clinic with presbyopic complaints. Both the Berlin questionnaire (9 (link)) was applied and a complete physical examination was performed by a thoracic medicine specialist (FE) to the participants to be included in the control group to exclude possible OSAS cases. The subjects who had a total score of <2 in the Berlin questionnaire and had no additional ocular and systemic diseases except controlled HT were included in the control group.
The patients who were <18 years old, who had any corneal diseases, ocular diseases requires continued medication (diseases such as glaucoma, uveitis, dry eyes, etc.), previous operation history of the eye in the past 6 months, contact lens use within last 4 weeks, the best corrected visual acuity (BCVA) <20/30 with spherical and cylindrical refraction exceeding ±3 diopter were excluded from the study. Patients who have systemic diseases that may affect the biomechanics of the cornea, such as Sjögren’s Disease, chronic renal failure, diabetes mellitus (DM), liver diseases, chronic obstructive pulmonary diseases, rheumatic, and oncological disorders were also excluded from the study.
The study group was selected according to their AHI value. While mild OSAS cases (AHI <15) were excluded, 32 eyes of 32 patients with moderate to severe OSAS (AHI ≥15; number of moderate case=16 and number of severe case=16) were included in the study (Group 1). The control group was determined as “Group 0” and 32 eyes of 32 patients were recruited in Group 0. Only the right eyes of the subjects were evaluated in both groups.
Biomechanical Phenomena
Chronic Obstructive Airway Disease
Contact Lenses
Cornea
Corneal Diseases
Diabetes Mellitus
Dry Eye
Eye
Faculty, Medical
Glaucoma
Healthy Volunteers
Kidney Failure, Chronic
Liver Diseases
Neoplasms
Ocular Refraction
Ophthalmologic Surgical Procedures
Patients
Pharmaceutical Preparations
Physical Examination
Regional Ethics Committees
Sleep
Sleep Apnea, Obstructive
Thoracic Diseases
Uveitis
Vision
Visual Acuity
This study included patients older than 16 years who underwent strabismus surgery at Dr. Sadi Konuk Education and Research Hospital, Ophthalmology department from January 2015 to December 2020. The study protocol followed the tenets of the Declaration of Helsinki. Approval from the local ethics committee was obtained and written informed consent from the participants was taken (August 16, 2021).
We retrospectively reviewed the records of patients from the hospital electronic system. The patients whose examinations were performed properly and data kept regularly and follow-up time over a year were included in the study. Paralytic, consecutive, and restrictive deviations were not included in the study. Patients with neurological and mental disorders, history of previous eye surgery, and trauma were excluded from the study.
Full ophthalmologic examination was performed in all patients. Best corrected visual acuity was measured with Snellen chart. Deviation at distance and near measured by prism cover test.
Fusion was obtained using the Worth-4-Dot test at distance fixation. Stereoacuity was examined using the Titmus test (Stereo Optical, Chicago, IL). Patients looked at the stereogram at distance of 40 cm while wearing polarizing glasses. The last correct target recognized was used as the subject’s stereopsis level. Stereoacuity was recorded as nil if the largest disparity could not be identified, and 6000 arcsec was accepted for nil stereopsis for the purpose of statistical analysis.
The following parameters were recorded: Age, refractive error, follow-up time, presence of amblyopia, deviation angle before and after from surgery, stereoacuity, and fusion ability preoperatively and postoperatively.
We retrospectively reviewed the records of patients from the hospital electronic system. The patients whose examinations were performed properly and data kept regularly and follow-up time over a year were included in the study. Paralytic, consecutive, and restrictive deviations were not included in the study. Patients with neurological and mental disorders, history of previous eye surgery, and trauma were excluded from the study.
Full ophthalmologic examination was performed in all patients. Best corrected visual acuity was measured with Snellen chart. Deviation at distance and near measured by prism cover test.
Fusion was obtained using the Worth-4-Dot test at distance fixation. Stereoacuity was examined using the Titmus test (Stereo Optical, Chicago, IL). Patients looked at the stereogram at distance of 40 cm while wearing polarizing glasses. The last correct target recognized was used as the subject’s stereopsis level. Stereoacuity was recorded as nil if the largest disparity could not be identified, and 6000 arcsec was accepted for nil stereopsis for the purpose of statistical analysis.
The following parameters were recorded: Age, refractive error, follow-up time, presence of amblyopia, deviation angle before and after from surgery, stereoacuity, and fusion ability preoperatively and postoperatively.
Amblyopia
Depth Perception
Eyeglasses
Mental Disorders
Operative Surgical Procedures
Ophthalmologic Surgical Procedures
Patients
Physical Examination
prisma
Refractive Errors
Regional Ethics Committees
Strabismus
Vision
Visual Acuity
Wounds and Injuries
The study included 49 AD patients and 48 healthy controls (HCs) matched by age, gender from the Department of Neurology at Xiangya Hospital of Central South University, between March 2020 and May 2022. The subjects were between 50 and 80 years of age, and the AD patients met the diagnostic criteria of “probable AD” in the 2011 edition of the National Institute on Aging and Alzheimer’s Association (NIA-AA) guidelines (McKhann et al., 2011 (link)). The exclusion criteria of the study were as follows: (1) Best-corrected visual acuity (BCVA) >6.00 D or with astigmatism >3.00 D, and (3) intraocular pressure (IOP) >21 mmHg. All participants were free of other neurologic, psychiatric disorders, and systemic diseases that may affect retina (such as diabetes mellitus and uncontrolled hypertension), as well as ocular diseases (including cataract, glaucoma, uveitis, epiretinal membrane, age-related macular degeneration, macular hole, eye trauma, and any eye surgery). The Ethics Committee of Xiangya Hospital of Central South University approved this study, and all subjects signed written informed consent.
Age-Related Macular Degeneration
Astigmatism
Cataract
Diabetes Mellitus
Diagnosis
Epiretinal Membrane
Ethics Committees, Clinical
Eye Injuries
Gender
Glaucoma
High Blood Pressures
Macular Holes
Nervous System Disorder
Ophthalmologic Surgical Procedures
Patients
Retina
Tonometry, Ocular
Uveitis
Vision
Visual Acuity
Top products related to «Ophthalmologic Surgical Procedures»
Sourced in Germany, Japan, United States
The Pentacam HR is an advanced corneal topography and anterior segment imaging system. It utilizes a rotating Scheimpflug camera to capture high-resolution, three-dimensional images of the anterior eye. The Pentacam HR provides detailed measurements of the cornea, anterior chamber, and other anterior segment structures.
Sourced in Germany, United States, Ireland, Italy, Japan
The IOLMaster 700 is an optical biometry device designed for accurate measurement of the eye's components. It utilizes optical coherence tomography (OCT) technology to provide precise data on the axial length, anterior chamber depth, and corneal curvature of the eye.
Sourced in United States
The Zeiss Ophthalmic Surgical Microscope is a precision optical instrument designed for use in ophthalmological surgical procedures. It provides high-quality magnification and illumination to facilitate detailed visualization of the surgical site.
Sourced in Germany, United States, Japan, Ireland, Switzerland, China
The IOLMaster 500 is a non-contact optical biometry device designed for ocular measurements. It utilizes optical coherence technology to precisely measure axial length, anterior chamber depth, and corneal curvature. The IOLMaster 500 is a diagnostic tool used in pre-operative evaluations for cataract and refractive surgery.
Sourced in Germany, United States, Ireland, Japan, United Kingdom, Lao People's Democratic Republic
The IOL Master is a non-contact optical biometry device used to measure various parameters of the eye, including axial length, anterior chamber depth, and corneal curvature. It provides precise measurements that are essential for calculating the appropriate intraocular lens power for cataract surgery.
Sourced in Germany, United States, Japan
The Pentacam is a diagnostic device that captures a 3D image of the anterior segment of the eye. It uses rotating Scheimpflug camera technology to obtain detailed measurements of the cornea, anterior chamber, lens, and iris.
Sourced in France, United States, Germany, Denmark, Brazil, China, Cameroon
Zoletil 50 is a veterinary anesthetic medication used in dogs, cats, and other animals. It contains the active ingredients tiletamine and zolazepam. Zoletil 50 is used to induce general anesthesia and provide sedation for medical procedures.
Sourced in United States, Switzerland
The Centurion Vision System is a specialized ophthalmic surgical device designed for cataract surgery. It provides precise control and customization of various surgical parameters to assist ophthalmologists during the procedure.
Sourced in Japan
The KR8800 is a multi-function clinical refraction system designed for use in ophthalmology and optometry practices. The device is capable of performing automated refraction, keratometry, and corneal topography measurements.
Sourced in United States
Tropicamide ophthalmic solution is a pharmaceutical product used in ophthalmology. It is a mydriatic agent that dilates the pupil.
More about "Ophthalmologic Surgical Procedures"
Ophthalmological Surgical Interventions: Advancing Eye Care through Innovation
Ophthalmological surgical procedures encompass a diverse range of interventions targeting the eye and its surrounding structures.
These procedures, which include cataract removal, corneal transplantation, refractive surgery, and vitreoretinal treatments, among others, aim to treat various ocular conditions, enhance visual function, and improve patient outcomes.
Researchers in this field leverage the latest advancements in surgical techniques, instrumentation, and medical technologies, such as the Pentacam HR, IOLMaster 700, ophthalmic surgical microscopes, IOLMaster 500, IOL Master, Pentacam, Zoletil 50, Centurion Vision System, KR8800, and Tropicamide ophthalmic solution, to optimize patient care and drive innovation in ophthalmology.
By carefully selecting and comparing surgical protocols, researchers can ensure reproducibility, enhance surgical outcomes, and advance the field of ophthalmic healthcare.
The use of AI-driven protocol optimization, as offered by PubCompare.ai, can help researchers identify the best procedures and products from literature, pre-prints, and patents, taking their ophthalmologic research to new heights.
Whether it's cataract removal, corneal transplantation, refractive surgery, or vitreoretinal interventions, the field of ophthalmological surgical procedures is constantly evolving, driven by the relentless pursuit of improved patient care and visual outcomes.
By embracing the latest technologies and innovative research methods, ophthalmologists and researchers can continue to make significant strides in this critical area of healthcare.
Ophthalmological surgical procedures encompass a diverse range of interventions targeting the eye and its surrounding structures.
These procedures, which include cataract removal, corneal transplantation, refractive surgery, and vitreoretinal treatments, among others, aim to treat various ocular conditions, enhance visual function, and improve patient outcomes.
Researchers in this field leverage the latest advancements in surgical techniques, instrumentation, and medical technologies, such as the Pentacam HR, IOLMaster 700, ophthalmic surgical microscopes, IOLMaster 500, IOL Master, Pentacam, Zoletil 50, Centurion Vision System, KR8800, and Tropicamide ophthalmic solution, to optimize patient care and drive innovation in ophthalmology.
By carefully selecting and comparing surgical protocols, researchers can ensure reproducibility, enhance surgical outcomes, and advance the field of ophthalmic healthcare.
The use of AI-driven protocol optimization, as offered by PubCompare.ai, can help researchers identify the best procedures and products from literature, pre-prints, and patents, taking their ophthalmologic research to new heights.
Whether it's cataract removal, corneal transplantation, refractive surgery, or vitreoretinal interventions, the field of ophthalmological surgical procedures is constantly evolving, driven by the relentless pursuit of improved patient care and visual outcomes.
By embracing the latest technologies and innovative research methods, ophthalmologists and researchers can continue to make significant strides in this critical area of healthcare.